NCT06553417Completed
Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic Dermatitis
Effectiveness and Tolerability of an Emollient 'Plus' Compared to Urea 10% in Patients With Mild-moderate Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 14 Aug 2024
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the effectiveness and tolerability of an Emollient Aqua Posae + Microesyl compared to urea 10% in patients with mild-moderate atopic dermatitis The main question it aims to answer is: " To evaluate the effectiveness and tolerability of an Emollient Aqua Posae + Microesyl compared to urea 10% in patients with mild-moderate atopic dermatitis age 18 years and above". Moisturizer application will be performed twice daily, 3 minutes after bathing, with a standardized dose using the Finger Tip Unit (FTU) method.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 8 Aug 2024
- Start date
- 1 Jun 2023
- Primary completion date
- 29 Sept 2023
- Lead sponsor
- Dr. Soetomo General Hospital
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06553417
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 1 Jun 2023 to the primary completion date, 29 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving topical or systemic immunomodulatory and/or immunosuppressant therapy.
- Patients receiving topical and/or systemic antibiotic therapy
- Patients receiving systemic antihistamine therapy (patients who require antihistamines during the study will be recorded on the observation sheet)
Other illness
- Patients with a history of allergies to ingredients contained in moisturizers
- Patients who clinically have other skin diseases such as psoriasis, seborrheic dermatitis, contact dermatitis or AD with secondary infections that can affect the SCORAD index parameters, skin hydration, skin pH and side effects on the skin area being assessed.
Other
- Pregnant and lactating patients.
Who the study is looking for
- Male or female aged ≥18 years
- AD patients who meet the criteria for AD diagnosis according to the Hanifin-Rajka criteria.
- Patients with mild-moderate AD according to the SCORAD index.
- Patients who have AD lesions on the hands and/or feet.
- Patients with good general condition.
- Patients are willing to participate in the study and sign the informed consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dr. Soetomo General Hospital Coordinator of this site? Confirm its status | Surabaya | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.